Survanta intratracheal 8ml vial

Survanta intratracheal 8ml vial

3826.50 جنيها

معلومات الدواء

الإسم التجاري

Survanta intratracheal 8ml vial -

الإسم العلمي 

Beractant

الشركات المنتجة

Abbvie ltd.,
Indicationsurvanta is indicated for prevention and treatment (
rescue
) of respiratory distress syndrome (rds) (hyaline membrane disease) in premature infants. survanta significantly reduces the incidence of rds, mortality due to rds and air leak complications.prevention: in premature infants less than 1250 g birth weight or with evidence of surfactant deficiency, give survanta as soon as possible, preferably within 15 minutes of birth.rescue: to treat infants with rds confirmed by x-ray and requiring mechanical ventilation, give survanta as soon as possible, preferably by 8 hours of age.
Indicationsurvanta is indicated for prevention and treatment (
rescue
) of respiratory distress syndrome (rds) (hyaline membrane disease) in premature infants. survanta significantly reduces the incidence of rds, mortality due to rds and air leak complications.prevention: in premature infants less than 1250 g birth weight or with evidence of surfactant deficiency, give survanta as soon as possible, preferably within 15 minutes of birth.rescue: to treat infants with rds confirmed by x-ray and requiring mechanical ventilation, give survanta as soon as possible, preferably by 8 hours of age.

تنبيه بخصوص المعلومات المتوفرة علي موقع دليل الدواء

بينما نعمل دائما علي تنقيح وتحسين البيانات المعروضة علي موقعنا إلا أننا ننصح دائما بعدم تعاطي أي دواء بدون إستشارة الطبيب المختص، ولا يتحمل الموقع أي مسئولية ناتجة عن سوء استخدام الأدوية بدون استشارة المختص، في حال وجدت أي بيانات خاطئة أو سعر دواء غير صحيح برجاء الإتصال بنا لتصحيحه.
الإبلاغ عن مشكلة

البدائل

311 دواء
اسم الدواء
السعر